Sign up to save your podcasts
Or
Share FELUDA- CRISPR BASED LOW-COST COVID-19 TEST - DEBOJYOTI CHAKRABORTY- SENIOR SCIENTIST CSIR'S- IGIB
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FELUDA- CRISPR BASED LOW-COST COVID-19 TEST - DEBOJYOTI CHAKRABORTY- SENIOR SCIENTIST CSIR'S- IGIB
#geneticediting #tata #tatacrispr #tatasons #covidtest #geneticengineering #crisprcas9 #dna #biotechnology #covid19 #covidtestkit
Dr. Debojyoti Chakraborty heads RNA Biology group at the Council of Scientific & Industrial Research’s, Institute of Genomics and Integrative Biology. Debojyoti Chakraborty's lab works on three broad research areas. The first of these is the development of efficient and specific tools for therapeutic genome editing, particularly for sickle cell anaemia. The second area is the systematic dissection of factors governing embryonic stem cell fate. The third area covers the use of cerebral organoids to address developmental questions such as the influence of DNA topology on transcription. Dr Debojyoti Chakraborty along with Dr Souvik Maiti has developed a crisprcas9 based cost-effective COVID test strip named after Feluda, a detective in a series of novels by filmmaker Satyajit Ray & they have partnered with Tata Son's for a commercial release.
Dr Debojyoti & team have also developed a new variant of the CRISPR-Cas9 gene-editing tool that has shown increase precision in editing genome while avoiding unintended changes in DNA.
https://www.rnabiologylab.com/
https://in.linkedin.com/in/debojyoti-chakraborty-b674b214
https://www.igib.res.in/?q=Debojyoti
https://www.debojyotichakraborty.com/
View all episodes
By THE ONE'S CHANGING THE WORLD - future tech meets sustainability podcast in India#geneticediting #tata #tatacrispr #tatasons #covidtest #geneticengineering #crisprcas9 #dna #biotechnology #covid19 #covidtestkit
Dr. Debojyoti Chakraborty heads RNA Biology group at the Council of Scientific & Industrial Research’s, Institute of Genomics and Integrative Biology. Debojyoti Chakraborty's lab works on three broad research areas. The first of these is the development of efficient and specific tools for therapeutic genome editing, particularly for sickle cell anaemia. The second area is the systematic dissection of factors governing embryonic stem cell fate. The third area covers the use of cerebral organoids to address developmental questions such as the influence of DNA topology on transcription. Dr Debojyoti Chakraborty along with Dr Souvik Maiti has developed a crisprcas9 based cost-effective COVID test strip named after Feluda, a detective in a series of novels by filmmaker Satyajit Ray & they have partnered with Tata Son's for a commercial release.
Dr Debojyoti & team have also developed a new variant of the CRISPR-Cas9 gene-editing tool that has shown increase precision in editing genome while avoiding unintended changes in DNA.
https://www.rnabiologylab.com/
https://in.linkedin.com/in/debojyoti-chakraborty-b674b214
https://www.igib.res.in/?q=Debojyoti
https://www.debojyotichakraborty.com/